NCT04611100View on ClinicalTrials.gov

Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions

Hilar CholangiocarcinomaBiliary Obstruction

Interventions

DEVICE

ELRA endoluminal radiofrequency ablation electrode (Taewoong, Seoul, Korea)

Intraductal radiofrequency ablation using ELRA endoluminal radiofrequency ablation electrode (Taewoong, Seoul, Korea) 10W 2 minutes at the obstructed bile duct before placing uncover self-expandable biliary metal stent

Trial Locations (1)

Unknown

Rajavithi Hospital, Bangkok

All Listed Sponsors

lead

Department of Medical Services Ministry of Public Health of Thailand

OTHER_GOV

NCT04611100 - Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma | Biotech Hunter | Biotech Hunter